Stock DVA DAVITA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials DaVita Inc.

Equities

DVA

US23918K1088

Healthcare Facilities & Services

Market Closed - Nyse
Other stock markets
 16:00:02 2024-04-26 EDT 		5-day change 1st Jan Change
133.5 USD +0.56% Intraday chart for DaVita Inc. +4.45% +27.44%
04-22 DaVita Inc. Announces Designing and Opening the First All-Electric Net-Zero Dialysis Center in the U.S, Powered by Solar Energy CI
04-10 Davita Announces Dennis Pullin to Its Board of Directors CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 9,612 13,149 11,592 6,728 9,570 11,709 - -
Enterprise Value (EV) 1 16,691 20,988 19,945 15,313 17,497 21,639 21,808 22,004
P/E ratio 14.2 x 18.6 x 12.8 x 12.8 x 14.1 x 15.5 x 13.6 x 12.2 x
Yield - - - - - - - -
Capitalization / Revenue 0.84 x 1.14 x 1 x 0.58 x 0.79 x 0.93 x 0.89 x 0.86 x
EV / Revenue 1.47 x 1.82 x 1.72 x 1.32 x 1.44 x 1.72 x 1.66 x 1.61 x
EV / EBITDA 7 x 8.83 x 8.05 x 7.39 x 7.06 x 8.43 x 8.17 x 7.86 x
EV / FCF 12.8 x 16.1 x 15.5 x 18.7 x 11.7 x 21.3 x 19.1 x 15.9 x
FCF Yield 7.82% 6.22% 6.46% 5.34% 8.52% 4.69% 5.23% 6.29%
Price to Book 4.43 x 9.33 x 14.6 x 9.48 x 8.81 x 8.52 x 7.2 x 6 x
Nbr of stocks (in thousands) 128,112 112,000 101,900 90,104 91,348 87,703 - -
Reference price 2 75.03 117.4 113.8 74.67 104.8 133.5 133.5 133.5
Announcement Date 20-02-10 21-02-11 22-02-10 23-02-22 24-02-13 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 11,388 11,551 11,619 11,610 12,140 12,567 13,110 13,669
EBITDA 1 2,383 2,376 2,478 2,072 2,479 2,566 2,669 2,799
EBIT 1 1,768 1,746 1,797 1,339 1,734 1,883 1,986 2,098
Operating Margin 15.53% 15.12% 15.47% 11.53% 14.28% 14.99% 15.15% 15.35%
Earnings before Tax (EBT) 1 1,195 1,318 1,518 966.3 1,177 1,212 1,302 1,684
Net income 1 811 773.6 978.4 560.4 691.5 758.5 798.3 820.7
Net margin 7.12% 6.7% 8.42% 4.83% 5.7% 6.04% 6.09% 6%
EPS 2 5.270 6.310 8.900 5.850 7.420 8.638 9.812 10.94
Free Cash Flow 1 1,306 1,304 1,289 817 1,491 1,015 1,141 1,384
FCF margin 11.47% 11.29% 11.1% 7.04% 12.28% 8.08% 8.7% 10.12%
FCF Conversion (EBITDA) 54.79% 54.89% 52.03% 39.44% 60.14% 39.56% 42.74% 49.44%
FCF Conversion (Net income) 161.02% 168.62% 131.78% 145.79% 215.61% 133.82% 142.93% 168.64%
Dividend per Share 2 - - - - - - - -
Announcement Date 20-02-10 21-02-11 22-02-10 23-02-22 24-02-13 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 2,938 2,944 2,818 2,927 2,949 2,917 2,873 3,000 3,121 3,146 3,021 3,129 3,193 3,214 3,142
EBITDA 1 645.3 564.2 511.3 603.9 506.2 450.3 530.1 615.7 713.4 610.3 587.9 663.4 699.2 637.2 619.2
EBIT 1 474.9 389.4 338.3 432.7 312 256.3 352 432 525 415 415.1 490.8 527.9 466.6 436.1
Operating Margin 16.16% 13.23% 12.01% 14.78% 10.58% 8.79% 12.25% 14.4% 16.82% 13.19% 13.74% 15.68% 16.53% 14.52% 13.88%
Earnings before Tax (EBT) 394.5 - 262.7 348.8 207.2 147.5 214.6 - - - - - - - -
Net income 1 259.8 187.5 162.1 224.8 105.4 68.1 115.5 178.7 246.6 150.7 188.1 212.6 238.7 182.6 -
Net margin 8.84% 6.37% 5.75% 7.68% 3.57% 2.33% 4.02% 5.96% 7.9% 4.79% 6.23% 6.79% 7.48% 5.68% -
EPS 2 2.360 1.790 1.610 2.300 1.130 0.7400 1.250 1.910 2.620 1.620 2.070 2.370 2.710 2.100 -
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 21-10-28 22-02-10 22-05-05 22-08-01 22-10-28 23-02-22 23-05-08 23-08-03 23-11-07 24-02-13 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 7,079 7,839 8,353 8,585 7,927 9,930 10,099 10,294
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.97 x 3.299 x 3.371 x 4.144 x 3.197 x 3.87 x 3.783 x 3.677 x
Free Cash Flow 1 1,306 1,304 1,289 817 1,491 1,015 1,141 1,384
ROE (net income / shareholders' equity) 28.4% 50.6% 93.8% 76.4% 89.2% 66.2% 57.6% 53.9%
ROA (Net income/ Total Assets) 4.56% 5.19% 5.88% 3.29% 4.67% 4.92% 5.17% 5.3%
Assets 1 17,796 14,908 16,638 17,023 14,822 15,412 15,455 15,491
Book Value Per Share 2 17.00 12.60 7.770 7.880 11.90 15.70 18.50 22.30
Cash Flow per Share 2 13.50 16.10 17.60 16.30 22.10 19.40 20.30 -
Capex 1 767 675 641 603 568 637 644 663
Capex / Sales 6.73% 5.84% 5.52% 5.19% 4.68% 5.07% 4.91% 4.85%
Announcement Date 20-02-10 21-02-11 22-02-10 23-02-22 24-02-13 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for DaVita Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
133.5 USD
Average target price
130.6 USD
Spread / Average Target
-2.19%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
DAVITA INC. Stock DaVita Inc.
+27.44% 11.71B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+11.62% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-3.97% 11.66B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. DVA Stock
  4. Financials DaVita Inc.